Regeneron Crashes 10% After Eylea Miss Drags Its Earnings Report

investors.com/news/technology/regeneron-stock-regeneron-pharmaceuticals-earnings-q1-2025

Regeneron stock tumbled Tuesday after the biotech giant reported a major revenue miss due to light sales of its eye drug Eylea.
The post Regeneron Crashes 10% After Eylea Miss Drags Its Earnings Report appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-04-29 13:42:12.
The Entire Business World on a Single Page. Free to Use →